NUCLWednesday, March 26, 2003

1:30 PM-5:20 PM Convention Center -- Room 390,Oral
Development of High-LET Therapeutic Radiopharmaceuticals
Other Alpha Emitters and Applications
Presidings:Thomas J. Ruth
Thomas M Behr
Organizers:Martin W. Brechbiel
D. Scott Wilbur
1:30 PM 110Production of high-LET radioisotopes at TRIUMF-ISAC
Thomas J. Ruth
2:00 PM 111Biomedical application of alpha-particle-emitting radium-223
Roy H. Larsen
2:30 PM 112Targeted alpha-particle radioimmunotherapy for prostate cancer
Dangshe Ma, Christine Hopf, Jason P. Gardner, Gerald P. Donovan, Norbert Schülke, Danielle Fisch, William C. Olson
2:50 PM 113Controlling the fate of Ac-225 and its daughters
Michael R. McDevitt
3:10 PM Intermission
3:30 PM 114Radiopeptide therapy with gastrin-receptor ligands: Toxicity and therapeutic efficacy of alpha, Auger electron, and beta emitters
Thomas M Behr, Martin P. Behe
4:00 PM 115Applications for short-lived alpha emitters
Stephen J. Kennel, Sandra M. Davern, Saed Mirzadeh
4:20 PM 116Peptide-targeted Pb-212/Bi-212 alpha radiation for melanoma therapy
Thomas P. Quinn, JianQing Chen, Weiwei Feng, Mark Hylarides, Alan Fritzberg
4:40 PM 117Radioimmunotherapy of intraperitoneal disseminated disease: Preliminary evaluation of Herceptin as a radioimmunoconjugate
Martin W. Brechbiel, Diane E. Milenic, Kayhan Garmestani, Alia Abdulla, Terrish Overstreet, Joe Flynn
5:00 PM Discussion
5:15 PM Concluding Remarks

Previous Session -- Development of High-LET Therapeutic Radiopharmaceuticals

Symposium Grid -- Division of Nuclear Chemistry & Technology -- Session Listing

The 225th ACS National Meeting, New Orleans, LA, March 23-27, 2003